News and Reports

From clinical breakthroughs to viral headlines, GLP-1 receptor agonists have transformed the healthcare landscape. But for Medicaid programs, the rapid growth of these treatments brings complex questions regarding adherence, safety, and sustainable coverage policy.  Join the Center for Evidence-based Policy for a deep dive into real-world Medicaid claims data. We’re moving beyond the headlines to show you exactly how these […]

Three states (Michigan, Missouri, and Washington) won the Center’s 2025 Evidence-based Health Policy Innovation Award this year! These three Medicaid programs and their public health partners built coordinated purchasing and treatment strategies for population-level elimination. Michigan, Missouri, and Washington’s Hepatitis C programs share 3 core features: a preferred Hepatitis C direct-acting anti-viral (DAA) drug selected […]

Medicaid Management Strategies for Practitioner Administered Drugs (PADs) This webinar explores Medicaid strategies for managing practitioner-administered drugs (PADs), with a special focus on oncology treatments. In 2019, almost 1 in 5 newly diagnosed cancer patients aged 18 to 64 were covered by Medicaid. How can states ensure that those patients receive high-quality care, while also […]

Medicaid and CHIP provide coverage to around 50% of children with special health care needs (CYSHCN).  This presentation provides a review of key principles, state strategies, and example programs to help state Medicaid agencies build a more integrated system of care for children with special needs. It also provides a single-state data snapshot of CYSHCN […]

Children and youth with special health care needs often receive services from many different care providers and settings, including specialty health care, education systems, and other state agencies such as child welfare. Medicaid and the Children’s Health Insurance Program play a significant role in the care of children with special needs. Developed through a collaboration […]

Since 2021, more than 20 states have passed legislation requiring the coverage of biomarker testing by state-regulated insurers – typically including both commercial plans and state Medicaid agencies. This presentation explores the impetus for this recent trend and uses a 50-state review to explain the structure of these laws and their potential impact on Medicaid […]

This presentation examines the ways in which state Medicaid agencies engage their clinical staff. It examines different clinical staff structures, leadership roles, and disciplines, the range of responsibilities and strategic portfolios held by clinical staff, and how clinical expertise can drive value for the agency. It also includes considerations for how states might optimize, extend, […]

The 2025 Oregon Child Integrated Dataset (OCID) legislative report is now available! Launched by the Oregon legislature in 2019, OCID is an objective data resource for policymakers to improve outcomes for the state’s children and families through evidence drawn from across traditional agency data silos. The report highlights OCID’s work for the last two years which included […]

We believe all states need access to high-quality evidence from reliable sources now more than ever, so we created the Evidence Synthesis Series to share information from recent research reports. We hope you will join us!  If you want to hear more about this, please subscribe to receive more information.   Webinar 1: The Role […]